The Trump administration has proposed rescinding 2024 regulations on ethylene oxide (EtO), a toxic industrial gas, in a move that analysts say would not only increase public exposure to the carcinogen but also curtail the Environmental Protection Agency's broader authority to strengthen hazardous emissions protections — even as updated science finds the chemical far more dangerous than once believed.
The Trump administration is seeking to roll back landmark 2024 rules that required the United States' ethylene oxide emitters to collectively reduce their emissions by approximately 90%, according to a new analysis reported by The Guardian. The proposed rescission comes despite research finding that EtO is roughly 60 times more carcinogenic than scientists believed when the previous regulatory framework was established in 2006.
Ethylene oxide is a colorless, odorless gas used primarily in the sterilisation of medical equipment and as an intermediate in the manufacture of chemicals including antifreeze and detergents. Long-term exposure has been linked to lymphoma, breast cancer, and other serious illnesses. Industrial facilities that emit EtO are located in communities across the country, with lower-income and minority neighborhoods often disproportionately affected.
The Biden administration's EPA issued updated rules in 2024 specifically to reflect advances in the science on EtO toxicity. The new standards tightened emission limits for commercial sterilisation facilities, chemical plants, and other industrial emitters, aiming to sharply reduce community exposure.
Critics of the rollback argue the move goes beyond deregulation of a single chemical. According to the analysis cited by The Guardian, the Trump administration's approach could structurally limit the EPA's ability to revisit and strengthen hazardous air pollutant standards in the future — even when new scientific evidence warrants it. This would represent a significant constraint on the agency's public health mandate under the Clean Air Act.
Proponents of the rollback, including some in the industrial sector, have argued that the 2024 regulations imposed costly compliance burdens on manufacturers and medical sterilisation facilities, potentially disrupting supply chains for sterile medical devices. The sterilisation industry has warned that overly stringent rules could threaten the availability of critical healthcare equipment.
Environmental health advocates and public health researchers have pushed back sharply, noting that the updated carcinogenicity findings make a strong scientific case for stricter — not looser — controls. They argue that rolling back the rules would leave millions of Americans, particularly those living near industrial emitters, at elevated cancer risk.
The EPA under the Trump administration has not publicly released a final rule or a detailed regulatory impact assessment as of publication. The broader deregulatory agenda at the agency has seen it revisit numerous environmental standards across air, water, and chemical safety domains since the administration took office.
Analysis
Why This Matters
- Communities living near ethylene oxide-emitting facilities — disproportionately low-income and minority neighbourhoods — could face increased long-term cancer risk if emission standards are relaxed in line with pre-2024 rules.
- The rollback may set a legal and administrative precedent that limits the EPA's capacity to update hazardous air pollutant rules as new scientific evidence emerges, weakening the agency's public health function beyond this single chemical.
- If successful, the move could invite legal challenges under the Clean Air Act, triggering years of regulatory uncertainty for both industry and affected communities.
Background
Ethylene oxide has been regulated as a hazardous air pollutant under the Clean Air Act for decades, but the science on its carcinogenicity has evolved considerably. In 2016, the EPA published a revised risk assessment concluding that EtO was significantly more dangerous than the 2006 estimate used to set existing standards — ultimately finding it roughly 60 times more carcinogenic. This revision prompted widespread concern, particularly in communities near commercial sterilisation facilities, and led to a wave of public health studies identifying elevated cancer rates in some affected areas.
The Biden EPA finalised new emission standards in 2024, requiring steep cuts across multiple industrial categories. The rules were among the most significant updates to hazardous air pollutant standards in years and were seen as a direct response to the updated science. Industry groups challenged aspects of the rules in court even before the change in administration.
The Trump administration has pursued broad deregulation of environmental rules since taking office in January 2025, targeting clean air, clean water, and climate-related regulations across multiple agencies. The EtO rollback fits within this wider pattern but carries particular public health significance given the strength of the scientific evidence underpinning the 2024 standards.
Key Perspectives
Trump Administration / Deregulatory Advocates: Argue the 2024 rules imposed excessive compliance costs on manufacturers and medical sterilisation facilities, potentially threatening the supply of sterile medical devices and placing undue burdens on American industry.
Environmental and Public Health Groups: Contend the rollback ignores compelling scientific evidence and will expose vulnerable communities to preventable cancer risk. They argue the EPA has a legal and moral obligation under the Clean Air Act to act on updated toxicological findings.
Critics/Skeptics: Legal analysts warn that limiting the EPA's authority to revise standards based on new science could face significant court challenges. Some also note the irony of rolling back rules in a political environment that otherwise emphasises American manufacturing and healthcare supply chain resilience.
What to Watch
- Whether the EPA publishes a formal proposed rule with a public comment period, and the volume and content of public responses from affected communities and health organisations.
- Court challenges from environmental groups or state attorneys general seeking to block the rescission under the Clean Air Act.
- Congressional responses, particularly from legislators representing districts with high concentrations of EtO-emitting facilities or elevated community cancer rates.